NEOS THERAPEUTICS,INC.Files An 8-K Submission of Matters to a Vote of Security Holders

Item5.07. Submission of Matters to a Vote of Security Holders.

The Company held its Annual Meeting of Stockholders (the Annual
Meeting) on June15, 2017. As of April26, 2017, the record date
for the Annual Meeting, there were 22,560,635 outstanding shares
of the Companys common stock. The Companys stockholders voted on
the following matters, which are described in detail in the
Companys Definitive Proxy Statement filed with the U.S.
Securities and Exchange Commission (SEC) on April28, 2017: (i)to
elect Vipin Garg and Greg Robitaille as ClassII directors of the
Company to each serve for a three-year term expiring at the
Companys annual meeting of stockholders in 2020 and until their
successors have been elected and qualified (Proposal 1) and
(ii)to ratify the appointment of RSM US LLP as the Companys
independent registered public accounting firm for the fiscal year
ending December31, 2017 (Proposal 2).

The Companys stockholders elected each of the ClassII director
nominees recommended for election in Proposal 1 at the Annual
Meeting. The Companys stockholders voted for ClassII directors as
follows:

The Companys stockholders approved Proposal 2. The votes cast at
the Annual Meeting were as follows:

No other matters were submitted to or voted on by the Companys
stockholders at the Annual Meeting.

* * *